Steven Reichling, CFO at Accelerate Diagnostics, Inc (AXDX), bought 600 shares at $15.23 ($9K) on 2015-09-29, disclosed to the SEC on 2015-10-01.
Open-market purchase of $9k AXDX by CFO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| Filing → |
| AXDX | SELL | 2023-02-15 | $3K | — | Filing → |
| AXDX | SELL | 2023-01-17 | $3K | — | Filing → |
| AXDX | BUY | 2022-08-22 | $7K | — | Filing → |